Targeted Therapy Resistance in Genitourinary Cancers: From Molecular Mechanisms to Clinical Strategies

Alcides Chaux

PDF(304 KB)
For Authors|For Editors|For Reviewers
PDF(304 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (205) : 335-342. DOI: 10.24976/Discov.Med.202638205.28
Review

Targeted Therapy Resistance in Genitourinary Cancers: From Molecular Mechanisms to Clinical Strategies

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(205): 335-342 https://doi.org/10.24976/Discov.Med.202638205.28

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(304 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉